The present invention provides an injectable pharmaceutical product comprisingan agent, the agent comprising an insoluble carrier to which is bound apeptide, the peptide being capable of binding fibrinogen such that the agentbinds via the bound fibrinogen to activated platelets in preference toinactive platelets, and wherein the peptide is not fibrinogen.